title: Bendamustine is effective in T-cell prolymphocytic leukaemia.
authors.affiliation: Service des Maladies du Sang, Centre Hospitalier Régional et Universitaire de Lille, Lille, France.
authors.forename: Charles
authors.initials: C
authors.lastname: Herbaux
authors.forename: Philippe
authors.initials: P
authors.lastname: Genet
authors.forename: Krimo
authors.initials: K
authors.lastname: Bouabdallah
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Pignon
authors.forename: Houria
authors.initials: H
authors.lastname: Debarri
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Guidez
authors.forename: Sarah
authors.initials: S
authors.lastname: Betrian
authors.forename: Xavier
authors.initials: X
authors.lastname: Leleu
authors.forename: Thierry
authors.initials: T
authors.lastname: Facon
authors.forename: Franck
authors.initials: F
authors.lastname: Morschhauser
authors.forename: Gandhi
authors.initials: G
authors.lastname: Damaj
authors.forename: Bruno
authors.initials: B
authors.lastname: Cazin
authors.forename: Loïc
authors.initials: L
authors.lastname: Ysebaert
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride; D004341:Drug Evaluation / Q000379:methods; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D015461:Leukemia, Prolymphocytic, T-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D018906:Antineoplastic Agents, Alkylating; D009588:Nitrogen Mustard Compounds; D000069461:Bendamustine Hydrochloride
keywords: T-PLL; alemtuzumab; bendamustine; salvage therapy